Association Between Preoperative Osteopenia and Prognosis in Breast Cancer Patients

  • 0Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; omori.sachie12@gmail.com.

|

|

Summary

This summary is machine-generated.

Preoperative osteopenia, a loss of bone mineral density, is linked to increased breast cancer recurrence, especially in premenopausal women. This finding highlights osteopenia as a significant prognostic factor for breast cancer survival.

Area Of Science

  • Oncology
  • Radiology
  • Bone Metabolism

Background

  • Osteopenia, characterized by reduced bone mineral density (BMD), is an emerging prognostic factor in various cancers.
  • The prognostic role of preoperative osteopenia in breast cancer patients is not well-established.
  • Clarifying this association is crucial for improving breast cancer patient outcomes.

Purpose Of The Study

  • To investigate the clinical significance of preoperative osteopenia as a prognostic factor in primary breast cancer.
  • To determine the relationship between osteopenia and patient survival, considering menopausal status.

Main Methods

  • Retrospective analysis of 532 primary breast cancer patients (Stage I-III) diagnosed between 2009 and 2017.
  • Osteopenia assessment using average pixel density (Hounsfield unit) in the 11th thoracic vertebra on preoperative CT scans.
  • Evaluation of recurrence-free survival (RFS) and overall survival (OS) in relation to osteopenia status and menopausal status.

Main Results

  • Osteopenia was present in 35.0% of patients.
  • Patients with osteopenia had significantly worse RFS (p=0.0275) but not OS.
  • In premenopausal patients, osteopenia was associated with significantly worse RFS and OS (p=0.0094 and p=0.0264, respectively) and was an independent prognostic factor for RFS (p=0.0266).

Conclusions

  • Preoperative osteopenia is independently associated with an increased risk of breast cancer recurrence.
  • The prognostic impact of osteopenia is particularly significant in premenopausal breast cancer patients.
  • These findings suggest that osteopenia assessment may aid in risk stratification for breast cancer recurrence.